Morton Freytag

graph of relations

Publications

  1. 2020
  2. 2018
  3. High expression of class III β-tubulin in upper gastrointestinal cancer types

    Höflmayer, D., Öztürk, E., Schroeder, C., Hube-Magg, C., Blessin, N. C., Simon, R., Lang, D. S., Neubauer, E., Göbel, C., Heinrich, M-C., Fraune, C., Möller, K., Armbrust, M., Freytag, M., Hinsch, A., Lühr, C., Noack, M., Reiswich, V., Weidemann, S., Bockhorn, M., Perez, D., Izbicki, J. R., Sauter, G. & Jacobsen, F., 12.2018, In: ONCOL LETT. 16, 6, p. 7139-7145 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target

    Drenckhan, A., Freytag, M., Supuran, C. T., Sauter, G., Izbicki, J. R. & Gros, S. J., 06.2018, In: J ENZYM INHIB MED CH. 33, 1, p. 1024-1033 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2016
  6. Influence of hypoxia-dependent factors on the progression of neuroblastoma

    Ameis, H. M., Drenckhan, A., Freytag, M., Izbicki, J. R., Supuran, C. T., Reinshagen, K., Holland-Cunz, S. & Gros, S. J., 02.2016, In: PEDIATR SURG INT. 32, 2, p. 187-92 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma

    Ameis, H. M., Drenckhan, A., Freytag, M., Izbicki, J. R., Supuran, C. T., Reinshagen, K., Holland-Cunz, S. & Gros, S. J., 2016, In: J ENZYM INHIB MED CH. 31, 3, p. 404-9 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review